Skip to main content
Equibles
PDEX logo

PDEX · Pro Dex Inc

Track PDEX — free

Use PDEX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$73.41 +11.66 (+18.88%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$235.16M
Shares
3.20M

PDEX metrics

91 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$73.41
Market cap
$235.16M

Price action

19 metrics
Price change (1W)
+17.4%
Price change (30D)
+10.8%
Price change (3M)
+12.6%
Price change (6M)
+62.1%
Price change (YTD)
+90.8%
Price change (1Y)
+60.5%
Trailing year
Price change (5Y)
+182.3%
52-week high
$73.41
52-week low
$23.91
Change from 52-week high
+0.0%
Change from 52-week low
+207.0%
Annualized volatility
63.9%
Beta
1.1
RSI (14D)
68.5
Price vs SMA 50
+18.4%
Price vs SMA 200
+42.3%
Avg volume (3M)
83,900
Relative volume
1.8
Average dollar volume
$5.23M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
3.20M

Valuation

12 metrics
P / E (TTM)
17.8
Trailing earnings · reciprocal yield 5.6%
PEG ratio
0.1
EV / revenue
3.1×
reciprocal yield 31.9%
EV / EBITDA
16.9×
reciprocal yield 5.9%
EV / EBIT
18.7×
reciprocal yield 5.3%
P / sales
3.0×
reciprocal yield 33.0%
P / book
4.9
reciprocal yield 20.3%
FCF yield
2.9%
TTM · current market cap
Buyback yield
1.2%
P / FCF
34.8
reciprocal yield 2.9%
P / operating cash flow
32.5
reciprocal yield 3.1%
Earnings yield
5.8%

Historical valuation

8 metrics
P / E historical average (3Y)
15.2×
reciprocal yield 6.6%
P / E historical average (5Y)
16.0×
reciprocal yield 6.3%
EV / revenue historical average (3Y)
2.0×
reciprocal yield 49.9%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 51.1%
EV / EBIT historical average (3Y)
13.2×
reciprocal yield 7.6%
EV / EBIT historical average (5Y)
14.3×
reciprocal yield 7.0%
EV / EBITDA historical average (3Y)
11.7×
reciprocal yield 8.6%
EV / EBITDA historical average (5Y)
12.9×
reciprocal yield 7.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
31.4%
Operating margin
16.8%
Trailing 12 months
Net margin
17.6%
Gross profit (TTM)
$24.34M
Operating profit (TTM)
$12.99M
Net income (TTM)
$13.66M
Trailing 12 months
Diluted EPS (TTM)
$4.12
FCF margin
8.7%
Effective tax rate
24.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.15

Growth

11 metrics
Revenue growth YoY
+16.6%
Year over year
Net income growth YoY
+138.7%
Revenue (TTM)
$77.55M
Trailing 12 months
EPS growth YoY
+160.6%
Shares change YoY
-2.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+18.9%
Revenue CAGR (5Y)
+15.3%
EPS CAGR (3Y)
+28.3%
EPS CAGR (5Y)
+21.3%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
28.7%
Return on assets
18.3%
Debt / equity
0.4
Current ratio
4.1
EBITDA (TTM)
$14.38M
Free cash flow (TTM)
$6.76M
Quick ratio
2.4
Interest coverage
16.0
Net debt / EBITDA
0.6
Return on invested capital
17.7%
Trailing 12 months
Net cash
−$8.17M
Latest balance sheet
Cash & equivalents
$8.19M
Total assets
$74.51M
Total debt
$17.51M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$7.24M
Capital expenditures (TTM)
$483,000
R&D (TTM)
$3.35M
SG&A (TTM)
$6.70M
Stock compensation (TTM)
$688,000
R&D / revenue
4.3%
Stock compensation / revenue
0.9%

Ownership (13F)

3 metrics
13F filers
67
13F filer change QoQ
+9
Institutional ownership
22.9%

Short interest

3 metrics
Short interest
6.1%
Latest settlement · 2.1 days to cover
Days to cover
2.1d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 788920 CUSIP 74265M205 13F (30d) 46 filings 46 filers Visit website Investor relations